Multivariable antigens complexed with targeting humanized monoclonal antibody

Details for Australian Patent Application No. 2008214077 (hide)

Owner Baylor Research Institute

Inventors Zurawski, Gerard

Agent Pizzeys

Pub. Number AU-A-2008214077

PCT Pub. Number WO2008/097817

Priority 60/888,029 02.02.07 US

Filing date 31 January 2008

Wipo publication date 14 August 2008

International Classifications

C07K 2/00 (2006.01) Peptides of undefined number of amino acids

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12P 19/00 (2006.01) Preparation of compounds containing saccharide radicals

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/097817 Priority application(s): WO2008/097817

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008214084-Use of arsenic compounds for treatment of pain and inflammation

2008214068-Electrocautery method and apparatus